Abstract
Nanoscale metal organic frameworks (NMOFs) have become excellent drug carriers for the treatment of cancer or other diseases, due to the advantages of large surface area, high drug loading, tunable structure and easy functionalization, with potential application in the field of drug delivery. In this paper, UiO-66 NMOF was synthesized using terephthalic acid as organic ligand and zirconium chloride as metal salt, and then biocompatible chitosan (CS) and PEGylated chitosan (CS-g-mPEG)-decorated NMOFs as drug carriers were constructed by surface modification, using 5-FU as the drug model. The structures, size and morphology were characterized by IR, XRD, DLS, SEM and TEM respectively. The results showed that when the concentration was 0.0872 M, the molar ratio was 1:1 and the acetic acid amount was 2.9 mL, the average particle size of NMOFs was 145.60 nm and 171.73 nm, respectively. The drug loading capacity and encapsulation rate could reach 15.7% and 52.8%. The in vitro controlled drug release results indicated that the release rate accelerated with increasing temperature and decreasing initial amount, greatly reduced under acidic conditions, and the coating of CS and CS-g-mPEG on the surface of UiO-66 had the effect of controlling drug release, further improved the bioavailability of 5-FU. The decorated UiO-66 NMOFs show excellent biocompatibility as nanodrug carriers and can avoid rapid degradation under gastric acid, which are more suitable for oral drug delivery.
Similar content being viewed by others
Availability of data and materials
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
DeSantis CE, Miller KD, Sauer AG et al (2019) Cancer statistics for African Americans. CA-A Cancer Journal for Clinicians 69:211–233
Li SM, Tan LF, Meng XW (2020) Nanoscale metal-organic frameworks: synthesis, biocompatibility, imaging applications, and thermal and dynamic therapy of tumors. Adv Func Mater 30(13):1908924
Cai MR, Chen GS, Qin LY et al (2020) Metal organic frameworks as drug targeting delivery vehicles in the treatment of cancer. Pharmaceutics 12:232
Yang JL, Wang H, Liu JY et al (2021) Recent advances in nanosized metal organic frameworks for drug delivery and tumor therapy. RSC Advance 11:3241–3263
Kreuter J (2007) Nanoparticles-a historical perspective. Int J Pharm 331(1):1–10
Scicluna MC, Vella-Zarb L (2020) The evolution of nanocarrier drug-delivery systems and recent advancements in covalent organic framework-drug systems. ACS Applied Nano Materials 3(4):3097–3115
Pooresmaeil M, Namazi H (2021) Developing a new photoluminescent, nanoporous, and biocompatible glycodendrimer for smart hepatic cancer treatment. Eur Polymer J 161:110866
Yang J, Yang YW (2020) Metal–organic frameworks for biomedical applications. Small 16(10):1906846
Cai X, Xie Z, Li D et al (2020) Nano-sized metal-organic frameworks: synthesis and applications. Coord Chem Rev 417:213366
Wang HS, Ding Y (2020) Recent advances of metal-organic frameworks applied in biomedicine. Acta Pharmaceutica Sinica 55(7):1511–1519
Gao P, Chen YY, Pan W et al (2021) Antitumor agents based on metal–organic frameworks. Angew Chem Int Ed 60:2–16
Férey G (2008) Hybrid porous solids: past, present, future. Chem Soc Rev 37(1):191–214
Horcajada P, Serre C, Férey G et al (2010) Hybrid nanocarriers for controlled delivery of antitumour and retroviral drugs delivery. Med Sci 26:761–767
Liu WC, Pan Y, Xiao WW et al (2019) Recent developments on zinc(II) metal-organic framework nanocarriers for physiological pH responsive drug delivery. Med Chem Commun 10:2038–2051
Luo ZD, Fan SR, Gua CY et al (2019) Metal–organic framework (MOF)-based nanomaterials for biomedical applications. Curr Med Chem 26:3341–3369
Javanbakht S, Shadi M, Mohammadian R et al (2019) Facile preparation of pH-responsive k-Carrageenan/tramadol loaded UiO-66 bio-nanocomposite hydrogel beads as a nontoxic oral delivery vehicle. J Drug Delivery Sci Technol 54:101311
Lawson HD, Walton SP, Chan C (2021) Metal−organic frameworks for drug delivery: a design perspective. ACS Appllied Materials Interfaces 13:7004–7020
Hidalgo T, Giménez-Marqués M, Bellido E et al (2017) Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers. Sci Rep 7:43099
Li L, Han SS, Zhao SQ et al (2020) Chitosan modified metal–organic frameworks as a promising carrier for oral drug delivery. RSC Adv 10:45130–45138
Farboudi A, Mahboobnia K, Chogan F et al (2020) UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid. Int J Biol Macromol 150:178–188
Alhodieb FS, Barkat A, Barkat HA et al (2022) Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles. Int J Biol Macromol 217:457–469
Simon-Yarza T, Mielcarek A, Couvreur P et al (2018) Nanoparticles of metal-organic frameworks: on the road to in vivo efficacy in biomedicine. Adv Mater 30(37):1707365
Pourmadadi M, Eshaghi MM, Ostovar S et al (2022) UiO-66 metal-organic framework nanoparticles as gifted MOFs to the biomedical application: A comprehensive review. J Drug Delivery Sci Technol 76:103758
Deng XY, Zhao J, Liu KW et al (2021) Stealth PEGylated chitosan polyelectrolyte complex nanoparticles as drug delivery carrier. J Biomater Sci Polym Ed 32(11):1387–1405
Funding
This work was supported by grants from Science and technology project of Xi'an (No. 21XJZZ0017), Scientific Research Program Funded by Shaanxi Provincial Science and Technology Department (No. 2023-YBGY-179, 2022GY-363), College Students' innovation and entrepreneurship training program (No. 2022012) and Project of Technology Innovation Guidance in Shaanxi Province (No. 2021QFY11-03).
Author information
Authors and Affiliations
Contributions
Data collation, Yinglu Li, Yurui Wang; analysis, Tianfu Zhao, Yanan Song; investigation, Yinglu Li, Tianfu Zhao; methodology, Jing Zhao, Fei Liang; project management, Jing Zhao, Fei Liang; writing—original draft, Yinglu Li, Tianfu Zhao; writing—reviewing and editing, Yinglu Li and Jing Zhao. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
No human or animal subjects were used in this research.
Competing interests
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, Y., Zhao, J., Wang, Y. et al. PEGylated chitosan decorated UiO-66 nanoscale metal–organic frameworks as promising carriers for drug delivery. Colloid Polym Sci 301, 1475–1486 (2023). https://doi.org/10.1007/s00396-023-05165-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00396-023-05165-3